178 related articles for article (PubMed ID: 9854502)
1. TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.
Eggermont AM
Anticancer Res; 1998; 18(5D):3899-905. PubMed ID: 9854502
[TBL] [Abstract][Full Text] [Related]
2. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors.
Nakamoto T; Inagawa H; Takagi K; Soma G
Anticancer Res; 2000; 20(6A):4087-96. PubMed ID: 11131677
[TBL] [Abstract][Full Text] [Related]
3. Regional application of TNF alpha in the treatment of cancer: a preclinical-clinical interactive program.
Eggermont AM; Manusama ER; ten Hagen TL
J Inflamm; 1995-1996; 47(1-2):104-13. PubMed ID: 8913937
[TBL] [Abstract][Full Text] [Related]
4. The success of TNF alpha in isolated limb perfusion for irresectable extremity soft tissue sarcomas, melanoma and carcinomas: observations in patients and preclinical perfusion models.
Eggermont AM
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1357-70. PubMed ID: 8854755
[No Abstract] [Full Text] [Related]
5. Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure.
Eggermont AM; van IJken MG; van Etten B; van der Sijp JR; ten Hagen TL; Wiggers T; Oudkerk M; de Boeck G; de Bruijn EA
Hepatogastroenterology; 2000; 47(33):776-81. PubMed ID: 10919031
[TBL] [Abstract][Full Text] [Related]
6. Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.
Eggermont AM; ten Hagen TL
Curr Oncol Rep; 2001 Jul; 3(4):359-67. PubMed ID: 11389822
[TBL] [Abstract][Full Text] [Related]
7. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
[TBL] [Abstract][Full Text] [Related]
8. An overview on the use of TNF-alpha: our experience with regional administration and developments towards new opportunities for systemic application.
van Der Veen AH; ten Hagen TL; de Wilt JH; van Ijken MG; Eggermont AM
Anticancer Res; 2000; 20(5B):3467-74. PubMed ID: 11131649
[TBL] [Abstract][Full Text] [Related]
9. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.
Taeger G; Grabellus F; Podleska LE; Müller S; Ruchholtz S
Int J Hyperthermia; 2008 May; 24(3):193-203. PubMed ID: 18392998
[TBL] [Abstract][Full Text] [Related]
11. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
Cherix S; Speiser M; Matter M; Raffoul W; Liénard D; Theumann N; Mouhsine E; Mirimanoff RO; Leyvraz S; Lejeune FJ; Leyvraz PF
J Surg Oncol; 2008 Sep; 98(3):148-55. PubMed ID: 18668638
[TBL] [Abstract][Full Text] [Related]
12. TNF-based isolated limb perfusion in unresectable extremity desmoid tumours.
Grünhagen DJ; de Wilt JH; Verhoef C; van Geel AN; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):912-6. PubMed ID: 16098709
[TBL] [Abstract][Full Text] [Related]
13. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma.
Grunhagen DJ; de Wilt JH; Graveland WJ; Verhoef C; van Geel AN; Eggermont AM
Cancer; 2006 Apr; 106(8):1776-84. PubMed ID: 16541435
[TBL] [Abstract][Full Text] [Related]
14. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
15. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
16. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
17. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response.
Hoving S; Seynhaeve AL; van Tiel ST; aan de Wiel-Ambagtsheer G; de Bruijn EA; Eggermont AM; ten Hagen TL
Anticancer Drugs; 2006 Sep; 17(8):949-59. PubMed ID: 16940805
[TBL] [Abstract][Full Text] [Related]
18. Extremity perfusion for sarcoma.
Hoekstra HJ
Surg Oncol Clin N Am; 2008 Oct; 17(4):805-24, ix. PubMed ID: 18722920
[TBL] [Abstract][Full Text] [Related]
19. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.
van Etten B; Brunstein F; van IJken MG; Marinelli AW; Verhoef C; van der Sijp JR; Guetens G; de Boeck G; de Bruijn EA; de Wilt JH; Eggermont AM
Ann Surg Oncol; 2004 Jun; 11(6):598-605. PubMed ID: 15172933
[TBL] [Abstract][Full Text] [Related]
20. Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs.
Lans TE; Grünhagen DJ; de Wilt JH; van Geel AN; Eggermont AM
Ann Surg Oncol; 2005 May; 12(5):406-11. PubMed ID: 15915375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
